MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-20-0006134
Scoat Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹34.51 Cr
▲ 16% YoY
Net profit · FY 2025
₹43.12 Lakh
Net margin 1.2%
EBITDA · FY 2025
₹88.36 Lakh
EBITDA margin 2.6%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹13 Cr
Satisfied ₹34.9 Lakh
Company age
20 yrs
Est. 2006
Employees · EPFO
15
Provident fund records
About Scoat Pharma Private Limited
Data last updated:
Scoat Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 10 April 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2006PTC049786. Its GSTIN is 36AAJCS8171J1ZT (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Javvaji Devi Aruna and Padmaja Rani Manepalli.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.54 A – Leap Industrial Area Survey No.342 Gajularamaram Quthbullapur Mandal, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.51 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹43.12 Lakh (net margin 1.2%) and EBITDA of ₹88.36 Lakh (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 10% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Scoat Pharma. As per MCA filings, the company has open charges of ₹13 Cr and satisfied charges of ₹34.9 Lakh on record. Court records list 13 cases involving the company, including 11 filed by the company and 2 filed against it; 6 cases are pending.
Scoat Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0006134). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website scoatpharma.com.
Company Details of Scoat Pharma Private Limited
CIN U24239TG2006PTC049786
Registration Number 049786
Incorporation Date 10 April 2006
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0006134
CIN History of Scoat Pharma Private Limited
Scoat Pharma has one previous CIN (Corporate Identification Number): U24239AP2006PTC049786. The current CIN is U24239TG2006PTC049786, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2006PTC049786 | Current |
| U24239AP2006PTC049786 | Previous |
Key People
Kolla Ramalingeswara Anand Swarup Additional Director Javvaji Devi Aruna Director Padmaja Rani Manepalli Director Recognitions & Rankings of Scoat Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.54 A – Leap Industrial Area Survey No.342 Gajularamaram Quthbullapur Mandal, Hyderabad, Telangana, India – 500072
- IndustryPharma, API Manufacturers
Comprehensive company report
Scoat Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Scoat Pharma Private Limited
Scoat Pharma operates one associated brand: Scoat Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides innovative pellets, contract manufacturing, and R&D for pharmaceutical companies. | scoatpharma.com |
Business Activity of Scoat Pharma Private Limited
The main business activity of Scoat Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Scoat Pharma Private Limited FY 2024 filings available
Scoat Pharma Private Limited reported revenue of ₹34.51 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹34.51 Cr ▲ 16%
Net profit · FY 2025
₹43.12 Lakh margin 1.2%
EBITDA · FY 2025
₹88.36 Lakh margin 2.6%
Compounded Annual Growth Rate (CAGR) of Scoat Pharma Private Limited
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 14%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 5%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 16% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Scoat Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹88.36 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹43.12 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Scoat Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Scoat Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Scoat Pharma Private Limited
Scoat Pharma has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kolla Ramalingeswara Anand Swarup Also directs: Boffin Pharmamed Solutions LLP | Additional Director | 24 Nov 2023 | 2 Years 10 Months | Current |
| Javvaji Devi Aruna Also directs: Sakksa Pharma Private Limited | Director | 06 Jan 2011 | 15 Years 9 Months | Current |
| Padmaja Rani Manepalli Also directs: Suraksha Pharma Private Limited, MMC Health Care Limited | Director | 28 Nov 2015 | 10 Years 10 Months | Current |
| Javvaji Anil Kumar Gupta Also directs: Boffin Pharmamed Solutions LLP, Sakksa Pharma Private Limited | Director | 17 Dec 2009 | 16 Years 10 Months | Current |
Peer Comparison of Scoat Pharma Private Limited
Scoat Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neoloba Specialty Private Limited | ₹35.84 Cr (FY 2025) | •••• | •••• | -62.0% | •••• | Dombivli, Maharashtra, India |
| Yojana Organics Private Limited | ₹35.61 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Ratnagiri, Maharashtra, India |
| Deft Organics Limited | ₹35.14 Cr (FY 2025) | •••• | •••• | -37.0% | •••• | Morar, Madhya Pradesh, India |
| Micro Molecules Private Limited | ₹34.7 Cr (FY 2025) | •••• | •••• | 61.0% | •••• | Ameerpet, Hyderabad-16, Telangana, India |
| Mahrshee Laboratories Private Limited | ₹34.56 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Panoli, Gujarat, India |
| Scoat Pharma Private Limited this company | ₹34.51 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Hyderabad, Telangana, India |
| V V L Pharma Private Limited | ₹34.25 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | New Panvel, Maharashtra, India |
| Larson Pharma Private Limited | ₹33.93 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Hyderabad, Telangana, India |
| Mahalakshmi Laboratories Private Limited | ₹33.56 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Hyderabad, Andhra Pradesh, India |
| Aspen Biopharma Labs Private Limited | ₹33.52 Cr (FY 2022) | •••• | •••• | 161.0% | •••• | Hyderabad, Telangana, India |
| Span Life Sciences Private Limited | ₹33.08 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Scoat Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Scoat Pharma Private Limited
Scoat Pharma Private Limited is audited by KRISHNA RAO AND ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KRISHNA RAO AND ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Scoat Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Scoat Pharma Private Limited
Open charges
₹13 Cr
Satisfied charges
₹34.9 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Feb 2024 | Others | ₹7 Cr | Open |
| 14 Feb 2024 | Others | ₹1 Cr | Open |
| 22 Aug 2015 | Others | ₹5 Cr | Open |
| 10 Jun 2020 | Others | ₹34.9 Lakh | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Scoat Pharma Private Limited
Scoat Pharma Private Limited has 13 court cases on record: 11 filed by Scoat Pharma, 2 filed against it. 6 cases are pending and 7 are disposed.
Total cases
13
Filed by the company
11
Filed against the company
2
Pending
6
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 1 | 6 |
| High courts | 2 | 1 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North, Delhi | Court case (CS (COMM.)) | Filed by the company against Ridley Life Science Pvt Ltd | Disposed |
| District court, Solapur, Maharashtra | Civil suit | Filed against the company by Vamsi Labs Ltd. | Disposed |
| District court, Rangareddy, Telangana | Criminal complaint | Filed by the company against M/S Sucharitha Power Systems, N.Shoba | Pending |
| District court, Rangareddy, Telangana | Court case (STC-NI) | Filed by the company against an individual | Pending |
| District court, Rangareddy, Telangana | Criminal complaint | Filed by the company against M/S Sucharitha Power Systems, N.Shoba | Pending |
Premium access
Full case history
All 13 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Scoat Pharma Private Limited
Scoat Pharma Private Limited has 10 MSME Form 1 returns on record between 2019 and 2024, listing 201 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Parshwa Pharma Chem Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Prayosha Health Care Private Limited | •••• | •••• | •••• |
| Atlas Life Sciences Private Limited | •••• | •••• | •••• |
| Corel Pharma Chem-Msme | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 10 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Scoat Pharma Private Limited
Scoat Pharma Private Limited has a workforce of 15 employees as of Mar 26, 2025.
Employee count
15
Active EPFO establishments
1
Employee growth
25%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Scoat Pharma Private Limited
Scoat Pharma Private Limited has 11 board changes on record since 2009: 4 appointments and 7 cessations. The latest: Kolla Ramalingeswara Anand Swarup was appointed as Additional Director on 24 Nov 2023.
Charges
A charge with Others of Rs. 5.00 Cr registered on 22 Aug 2015 with Charge ID 10592307 was modified on 31 May 2025.
AGM
Scoat Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Scoat Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 7.00 Cr with Charge ID 100879363 was registered on 14 Feb 2024.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100879347 was registered on 14 Feb 2024.
Charges
A charge registered on 10 Jun 2020 via Charge ID 100347071 with Others was fully satisfied on 15 Dec 2023.
Appointed
Kolla Ramalingeswara Anand Swarup was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 0.35 Cr with Charge ID 100347071 was registered on 10 Jun 2020.
Ceased
Padmaja Rani Manepalli ceased to be Additional Director.
Ceased
Kolla Ramalingeswara Anand Swarup ceased to be Director.
Appointed
Padmaja Rani Manepalli was appointed as Director.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 10592307 was registered on 22 Aug 2015.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Scoat Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Scoat Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Scoat Pharma Private Limited
Scoat Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCS8171J1ZT | Telangana | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Scoat Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scoat Pharma Private Limited
Scoat Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 10 April 2006 (20+ years old) and is registered under CIN U24239TG2006PTC049786.
Scoat Pharma reported revenue of ₹34.51 Cr for FY 2025 (up 16% YoY).
Scoat Pharma has 4 current directors:
- Kolla Ramalingeswara Anand Swarup - Additional Director
- Javvaji Devi Aruna - Director
- Padmaja Rani Manepalli - Director
- Javvaji Anil Kumar Gupta - Director
Scoat Pharma reported a net profit of ₹43.12 Lakh (net margin 1.2%) and EBITDA of ₹88.36 Lakh (EBITDA margin 2.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Scoat Pharma is 14% over three years and 10% over five years. In the latest year (FY 2025) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Scoat Pharma is 36AAJCS8171J1ZT, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Scoat Pharma is U24239TG2006PTC049786. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scoat Pharma has 13 court cases on record: 11 filed by the company and 2 filed against it. 6 are pending. Most are in the district courts.
Scoat Pharma was incorporated on 10 April 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Scoat Pharma by revenue are Neoloba Specialty Private Limited, Yojana Organics Private Limited, Deft Organics Limited, Micro Molecules Private Limited, Mahrshee Laboratories Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Kolla Ramalingeswara Anand Swarup was appointed as Additional Director on 24 Nov 2023. Padmaja Rani Manepalli ceased to be Additional Director on 30 Sep 2016. Kolla Ramalingeswara Anand Swarup ceased to be Director on 28 Nov 2015. Scoat Pharma has 11 board changes on record in total.
Yes, Scoat Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0006134).